Benjamin Deaton, MD
Critical Care Medicine · Baton Rouge, LANPI 1376803437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,060, 7.7 times the $137 reported in 2022.
Across 86 payments — averaging $26.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$482
- Abiomed$326
- Grifols USA, LLC$182
- AstraZeneca$159
- Nuwellis, Inc.$137
- Baxter Healthcare$106
- plus $867 from 21 others
What the payments were for
- Speaking & faculty fees$1376%
- Food & beverage$2,12294%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 14 | $482 |
| Abiomed | 7 | $326 |
| Grifols USA, LLC | 7 | $182 |
| AstraZeneca | 8 | $159 |
| Nuwellis, Inc. | 1 | $137 |
| Baxter Healthcare | 5 | $106 |
| Merck | 4 | $81 |
| Actelion Pharmaceuticals US, Inc. | 3 | $76 |
| Johnson & Johnson | 3 | $74 |
| Coaptech, Inc. | 2 | $66 |
| Electromed, Inc. | 9 | $65 |
| Boehringer Ingelheim | 3 | $55 |
| Viatris Specialty LLC | 2 | $50 |
| United Therapeutics Corporation | 2 | $43 |
| Verona Pharma, Inc. | 2 | $42 |
| UCB, Inc. | 2 | $41 |
| Shionogi Inc | 2 | $37 |
| Medtronic | 1 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Vifor Pharma, Inc. | 1 | $27 |
| Insmed, Inc. | 1 | $23 |
| La Jolla Pharmaceutical Company | 1 | $22 |
| Mylan Specialty L.p. | 1 | $22 |
| GSK | 1 | $20 |
| Pfizer | 1 | $18 |
| Liquidia Technologies, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,259 in reported general payments places this provider in the 65th percentile of 72 critical care medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Baton Rouge
- Abdulla Majid-MoosaBaton Rouge$202K
- Ahmad SharayahBaton Rouge$12K
- Ronald FieldsBaton Rouge$11K
- Merissa BraudBaton Rouge$8K
- James VermaelenBaton Rouge$8K
- Mostafa AboubakrBaton Rouge$6K
- James FordBaton Rouge$6K
- Vincent ValentineBaton Rouge$6K
- Daniel ReesBaton Rouge$4K
- Owen StellBaton Rouge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.